• Explore /
  • Poster
  • / A phase I/II study of LOAd703, a TMZ-CD40L/4-1BBL-armed oncolytic adenovirus, combined with nab-paclitaxel and gemcitabine in advanced pancreatic cancer.

A phase I/II study of LOAd703, a TMZ-CD40L/4-1BBL-armed oncolytic adenovirus, combined with nab-paclitaxel and gemcitabine in advanced pancreatic cancer.

Abstract Poster

Authors

null

Benjamin Leon Musher

Baylor College of Medicine, Houston, TX

Benjamin Leon Musher , Brandon George Smaglo , Wasif Abidi , Mohamed Othman , Kalpesh Patel , Salmaan Jawaid , James Jing , Amanda Brisco , Jessica Wenthe , Emma Eriksson , Gustav J. Ullenhag , Linda Sandin , Bambi Grilley , Justyna Leja-Jarblad , Susan G. Hilsenbeck , Malcolm K. Brenner , Eric Keith Rowinsky , Angelica Sara Ingrid Loskog

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Pancreatic Cancer

Clinical Trial Registration Number

NCT02705196

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 4138)

DOI

10.1200/JCO.2022.40.16_suppl.4138

Abstract #

4138

Poster Bd #

124

Abstract Disclosures

Similar Posters

First Author: Benjamin Leon Musher

First Author: Anita Ahmed Turk

First Author: Chao Yin

First Author: Ying Cheng